Skip to content

Sucampo Pharmaceuticals, Inc.

Delisted

CIK 1365216fmd_0YZ7WF54N81ZAKN4N7K7SSRJPQManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2009 to Sep 30, 2017, 31 periods

Latest annual · FY2016

Millions
Total revenues
230
Gross profit
154
Operating income
54
Net income
18
Free cash flow
7

Latest quarter · Q3 FY2017

Millions
Total revenues
61
Gross profit
44
Operating income
21
Net income
10
Free cash flow
(5)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2013 to FY2016
+36.9%
Revenue, 5 yearsFY2011 to FY2016
+33.3%
Net income, 5 yearsFY2011 to FY2016
n/m

Sucampo Pharmaceuticals, Inc. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2016FY2015ChangeSource
Revenue$230.1 million$153.2 million+50.2%10-K 2017-03-08 · proof
Gross profit$154.1 million$116.4 million+32.3%10-K 2017-03-08 · proof
Operating income$53.9 million$44.5 million+21.2%10-K 2017-03-08 · proof
Net income$18.5 million$33.4 million-44.6%10-K 2017-03-08 · proof
Cash from operating activities$8.3 million$18.6 million-55.3%10-K 2017-03-08 · proof
Free cash flow$7.1 million$15 million-52.8%10-K 2017-03-08 · proof
Total assets$520.9 million$457.2 million+13.9%10-K 2017-03-08 · proof
Total liabilities$353.8 million$370.7 million-4.6%10-K 2017-03-08 · proof
Cash and cash equivalents$198.3 million$108.3 million+83.1%10-K 2017-03-08 · proof
What was Sucampo Pharmaceuticals, Inc.'s revenue in fiscal 2016?
Sucampo Pharmaceuticals, Inc. reported revenue of $230.1 million for fiscal 2016 (the year ended Dec 31, 2016), against $153.2 million the year before (+50.2%). Source: the 10-K filed with the SEC on Mar 8, 2017. SEC
What was Sucampo Pharmaceuticals, Inc.'s gross profit in fiscal 2016?
Sucampo Pharmaceuticals, Inc. reported gross profit of $154.1 million for fiscal 2016 (the year ended Dec 31, 2016), against $116.4 million the year before (+32.3%). Source: the 10-K filed with the SEC on Mar 8, 2017. SEC
What was Sucampo Pharmaceuticals, Inc.'s operating income in fiscal 2016?
Sucampo Pharmaceuticals, Inc. reported operating income of $53.9 million for fiscal 2016 (the year ended Dec 31, 2016), against $44.5 million the year before (+21.2%). Source: the 10-K filed with the SEC on Mar 8, 2017. SEC
What was Sucampo Pharmaceuticals, Inc.'s net income in fiscal 2016?
Sucampo Pharmaceuticals, Inc. reported net income of $18.5 million for fiscal 2016 (the year ended Dec 31, 2016), against $33.4 million the year before (-44.6%). Source: the 10-K filed with the SEC on Mar 8, 2017. SEC
What was Sucampo Pharmaceuticals, Inc.'s cash from operating activities in fiscal 2016?
Sucampo Pharmaceuticals, Inc. reported cash from operating activities of $8.3 million for fiscal 2016 (the year ended Dec 31, 2016), against $18.6 million the year before (-55.3%). Source: the 10-K filed with the SEC on Mar 8, 2017. SEC
What was Sucampo Pharmaceuticals, Inc.'s free cash flow in fiscal 2016?
Sucampo Pharmaceuticals, Inc. reported free cash flow of $7.1 million for fiscal 2016 (the year ended Dec 31, 2016), against $15 million the year before (-52.8%). Source: the 10-K filed with the SEC on Mar 8, 2017. SEC
What are Sucampo Pharmaceuticals, Inc.'s total assets?
As of Dec 31, 2016, Sucampo Pharmaceuticals, Inc. reported total assets of $520.9 million, against $457.2 million a year earlier (+13.9%). Source: the 10-K filed with the SEC on Mar 8, 2017. SEC
What are Sucampo Pharmaceuticals, Inc.'s total liabilities?
As of Dec 31, 2016, Sucampo Pharmaceuticals, Inc. reported total liabilities of $353.8 million, against $370.7 million a year earlier (-4.6%). Source: the 10-K filed with the SEC on Mar 8, 2017. SEC
What are Sucampo Pharmaceuticals, Inc.'s cash and cash equivalents?
As of Dec 31, 2016, Sucampo Pharmaceuticals, Inc. reported cash and cash equivalents of $198.3 million, against $108.3 million a year earlier (+83.1%). Source: the 10-K filed with the SEC on Mar 8, 2017. SEC

Read from the FinancialMD API on Nov 14, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1365216&period_type=annual&limit=5"

Information only, not investment advice.